Perrigo Company has entered into an agreement with Founder Pharma, a subsidiary of Southwest Synthetic Pharmaceutical to supply infant formula manufactured in its US facilities.
Subscribe to our email newsletter
The product will be sold and distributed by Founder Pharma in China.
Perrigo chairman and CEO Joseph C Papa said Synthetic’s strong brand, marketing, and distribution would help them grow in the robust infant formula market.
Perrigo Company develops, manufactures and distributes OTC and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, and active pharmaceutical ingredients (API).
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.